COVID-19: Third death, Govt allows use of anti-HIV drugs for high-risk patients above the age of 60


India reported its third novel coronavirus (COVID-19) death Tuesday — a 63-year-old man in Mumbai with a travel history to Dubai, and had underlying conditions of high blood pressure and heart disease.

With more fresh cases being reported, the total number of confirmed cases has climbed to 137, including 14 people who have recovered.

And after two COVID-positive Italian tourists — a 69-year-old man and his 70-year-old wife — who were administered the Lopinavir/Ritonavir combination, usually a second-line HIV medication, recovered in Jaipur, the Union Health Ministry recommended use of the antiviral drugs on a ‘case-to-case basis’ for ‘high-risk patients’ aged above 60 years with underlying conditions.



Please enter your comment!
Please enter your name here